• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

登革病毒和寨卡病毒III结构域蛋白的表达与纯化

Expression and purification of domain III proteins from Dengue and Zika viruses.

作者信息

Corzo-Gómez Josselin, García-Cordero Julio, Montes Gómez Alfredo E, Bernal-Siria Karen, Namorado-Tónix Karime, Gutierrez-Castañeda Benito, Cedillo-Barrón Leticia

机构信息

Departamento de Biomedicina Molecular CINVESTAV IPN, Av. IPN # 2508 Col, San Pedro Zacatenco, 07360, México City, Mexico.

Immunology Department (UMF) Facultad de Estudios Superiores-Iztacala, Universidad Nacional Autonoma de México, Av. de los Barrios 1, Los Reyes Iztacala, Tlalnepantla, 54090, Edo. de México, Mexico.

出版信息

Protein Expr Purif. 2019 Oct;162:38-43. doi: 10.1016/j.pep.2019.05.005. Epub 2019 May 18.

DOI:10.1016/j.pep.2019.05.005
PMID:31112759
Abstract

The envelope (E) protein from Dengue and Zika viruses comprises three functional and structural domains (DI, DII, and DIII). Domain III induces most of the neutralizing antibodies and, as such, is considered as having the highest antigenic potential for the evaluation of population-level surveillance and for detecting past infections in both Dengue and Zika patients. The present study aimed to clone and express recombinant proteins of domain III from Dengue virus serotype 2 and from Zika virus in a prokaryotic system, as well as evaluate their immunogenicity and cross-reactivity. Both antigens were successfully purified and their antigenicity was assessed in mice. The antibodies elicited by domain III of Zika and Dengue virus antigens recognized specifically the native proteins in infected cells. Furthermore, the antigens showed a more specific immunogenic response than that of domain III proteins from Dengue virus. The generated recombinant proteins can be potentially used in subunit vaccines or for surveillance studies.

摘要

登革热病毒和寨卡病毒的包膜(E)蛋白由三个功能和结构域(DI、DII和DIII)组成。结构域III诱导产生大多数中和抗体,因此,对于评估人群水平的监测以及检测登革热和寨卡病毒患者过去的感染情况而言,它被认为具有最高的抗原潜力。本研究旨在克隆并在原核系统中表达登革热病毒2型和寨卡病毒结构域III的重组蛋白,同时评估它们的免疫原性和交叉反应性。两种抗原均成功纯化,并在小鼠中评估了它们的抗原性。寨卡病毒和登革热病毒抗原的结构域III引发的抗体能够特异性识别感染细胞中的天然蛋白。此外,与登革热病毒结构域III蛋白相比,这些抗原表现出更具特异性的免疫原性反应。所产生的重组蛋白有可能用于亚单位疫苗或监测研究。

相似文献

1
Expression and purification of domain III proteins from Dengue and Zika viruses.登革病毒和寨卡病毒III结构域蛋白的表达与纯化
Protein Expr Purif. 2019 Oct;162:38-43. doi: 10.1016/j.pep.2019.05.005. Epub 2019 May 18.
2
Dengue and Zika Virus Domain III-Flagellin Fusion and Glycan-Masking E Antigen for Prime-Boost Immunization.登革热和 Zika 病毒结构域 III-鞭毛蛋白融合和糖基掩蔽 E 抗原用于初次-加强免疫。
Theranostics. 2019 Jul 9;9(16):4811-4826. doi: 10.7150/thno.35919. eCollection 2019.
3
Structural basis of potent Zika-dengue virus antibody cross-neutralization.强效寨卡-登革热病毒抗体交叉中和的结构基础。
Nature. 2016 Aug 4;536(7614):48-53. doi: 10.1038/nature18938. Epub 2016 Jun 23.
4
A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.植物源疫苗可预防小鼠感染致死性西尼罗河病毒,而不增强寨卡病毒或登革热病毒的感染力。
Vaccine. 2018 Mar 27;36(14):1846-1852. doi: 10.1016/j.vaccine.2018.02.073. Epub 2018 Feb 26.
5
DNA-immunisation with dengue virus E protein domains I/II, but not domain III, enhances Zika, West Nile and Yellow Fever virus infection.用登革病毒E蛋白结构域I/II而非结构域III进行DNA免疫,会增强寨卡病毒、西尼罗河病毒和黄热病病毒的感染。
PLoS One. 2017 Jul 25;12(7):e0181734. doi: 10.1371/journal.pone.0181734. eCollection 2017.
6
A single-dose circular RNA vaccine prevents Zika virus infection without enhancing dengue severity in mice.一剂环状 RNA 疫苗可预防寨卡病毒感染,而不会加重小鼠登革热的严重程度。
Nat Commun. 2024 Oct 16;15(1):8932. doi: 10.1038/s41467-024-53242-0.
7
Virus-like particles that display Zika virus envelope protein domain III induce potent neutralizing immune responses in mice.展示寨卡病毒包膜蛋白结构域 III 的病毒样颗粒在小鼠中诱导强烈的中和免疫应答。
Sci Rep. 2017 Aug 9;7(1):7679. doi: 10.1038/s41598-017-08247-9.
8
Understanding Zika Virus Stability and Developing a Chimeric Vaccine through Functional Analysis.了解寨卡病毒的稳定性并通过功能分析开发嵌合疫苗。
mBio. 2017 Feb 7;8(1):e02134-16. doi: 10.1128/mBio.02134-16.
9
An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design.一种经包膜修饰的四价登革病毒样颗粒疫苗对黄病毒疫苗设计具有启示意义。
J Virol. 2017 Nov 14;91(23). doi: 10.1128/JVI.01181-17. Print 2017 Dec 1.
10
Animal Models for Dengue and Zika Vaccine Development.登革热和 Zika 疫苗开发的动物模型。
Adv Exp Med Biol. 2018;1062:215-239. doi: 10.1007/978-981-10-8727-1_16.

引用本文的文献

1
Purification, refolding, and pH-dependent stability evaluation of Zika virus EDIII protein.寨卡病毒包膜蛋白结构域III(EDIII)的纯化、复性及pH依赖性稳定性评估
Int Microbiol. 2025 Jun 6. doi: 10.1007/s10123-025-00679-y.
2
Refocusing the Immune Response to Selected Epitopes on a Zika Virus Protein Antigen by Nanopatterning.通过纳米图案化使免疫反应重新聚焦在寨卡病毒蛋白抗原的选定表位上。
Adv Healthc Mater. 2021 Aug;10(15):e2002140. doi: 10.1002/adhm.202002140. Epub 2021 Apr 30.
3
Dengue mouse models for evaluating pathogenesis and countermeasures.
登革热小鼠模型用于评估发病机制和对策。
Curr Opin Virol. 2020 Aug;43:50-58. doi: 10.1016/j.coviro.2020.09.001. Epub 2020 Sep 17.